Cargando…

Ceftaroline in severe community-acquired pneumonia

Severe community-acquired pneumonia (SCAP) is associated with high mortality. Factor such as early adequate antibiotic therapy, delay in intensive care unit (ICU) care and pneumonia caused by resistant pathogens are associated with worse outcomes in SCAP patients. Ceftaroline is a fifth-generation c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cilloniz, Catia, Pericàs, Juan M, Rojas, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2022
Materias:	New Antimicrobial Alternatives in the Treatment of Pneumonia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106200/ https://www.ncbi.nlm.nih.gov/pubmed/35488821 http://dx.doi.org/10.37201/req/s01.06.2022

Ejemplares similares

New evidence in severe pneumonia: meropenemvaborbactam
por: Guillot, María Forteza, et al.
Publicado: (2022)

New evidence in severe pneumonia: imipenem/ cilastatin/relebactam
por: Girón, Rosa Mª, et al.
Publicado: (2022)

Ceftolozane-tazobactam in nosocomial pneumonia
por: Candel, Francisco Javier, et al.
Publicado: (2022)

Ceftobiprole medocaril
por: Méndez, Raúl, et al.
Publicado: (2022)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

Aspiration pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Prevalence and correlates of treatment failure among Kenyan children hospitalised with severe community-acquired pneumonia: a prospective study of the clinical effectiveness of WHO pneumonia case management guidelines
por: Agweyu, Ambrose, et al.
Publicado: (2014)

Ceftaroline
por: Soriano, Alex
Publicado: (2021)

Computed tomography in children with community-acquired pneumonia
por: Andronikou, Savvas, et al.
Publicado: (2017)

Lung ultrasound for the diagnosis of community-acquired pneumonia in children
por: Stadler, Jacob A. M., et al.
Publicado: (2017)

Community-acquired pneumonia in children — a changing spectrum of disease
por: le Roux, David M., et al.
Publicado: (2017)

Value of syndromic panels in the management of severe community-acquired pneumonia
por: Burillo, Almudena, et al.
Publicado: (2022)

Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents
por: Andronikou, Savvas, et al.
Publicado: (2017)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Community-acquired pneumonia in critically ill very old patients: a growing problem
por: Cillóniz, Catia, et al.
Publicado: (2020)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
por: Cillóniz, Catia, et al.
Publicado: (2020)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Torres, Antoní, et al.
Publicado: (2023)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
por: Maselli, Diego J, et al.
Publicado: (2012)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience
por: Santos, Paul D, et al.
Publicado: (2013)

Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE
por: Carreno, Joseph J., et al.
Publicado: (2014)

809 Contemporary Experience with Ceftaroline Fosamil for the Treatment of Community-acquired Bacterial Pneumonia
por: Johnson, Leonard B, et al.
Publicado: (2014)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections
por: Goodman, Julian J, et al.
Publicado: (2012)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
por: Mpenge, Mbiye A, et al.
Publicado: (2015)

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
por: Maggiore, Christy, et al.
Publicado: (2015)

Recurrent ventilator-associated pneumonia caused by “difficult to treat” resistance Pseudomonas aeruginosa
por: Rodríguez-Aguirregabiria, Montserrat, et al.
Publicado: (2022)

Science or Fiction: Use of Nesiritide as a First-Line Agent?
por: Noviasky, John A, et al.
Publicado: (2003)

Assessing the risk of stroke from neck manipulation: a systematic review
por: Haynes, M J, et al.
Publicado: (2012)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
por: Cillóniz, Catia, et al.
Publicado: (2018)

Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician
por: Costa, José Ricardo Gimeno
Publicado: (2022)

Patient Detection of a Drug Dispensing Error by Use of Physician-Provided Drug Samples
por: Ashley, Elizabeth S Dodds, et al.
Publicado: (2002)

Assessment of food habits in children aged 6–12 years and the risk of caries
por: Doichinova, Liliya, et al.
Publicado: (2015)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tlnjtcmposj4lcu0e99da4eip0